Suvizumab

A4DAB250 | Phase-I

Target HIV-1 gp120

Isotype / Subclass G1 / None

Company

Kaketsuken Kumamoto University University of Missouri-Columbia

Clinical Status Phase-I

Format Whole mAb

Synonyms

KD-247 KD247 KD 247

pH Formulation —

IMGT PubChem (160698802) PubChem (381125776) PubChem (472407503) PubChem (480403090) PubChem (481987978) PubChem (513907379) Thera-SAbDab YAbS

Avg A4D Score

-0.6918

Score Range

-0.69

Structures

1

Structure ID	Source PDB	Seq. Identity	Avg. A4D Score	pH (Min Agg.)	pH (Max Agg.)	Score CDR	Score non-CDR
A4DAB250_3ntc_H_L	3ntc	100%	-0.6918	6.5	9.0	-0.2463	-0.7509